miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.

miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39255366

about

MicroRNA Regulation of Human Breast Cancer Stem Cells microRNA regulation of Wnt signaling pathways in development and disease The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.Noncoding RNA as therapeutic targets for hepatocellular carcinoma.A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese.Role of microRNAs in inflammation-associated liver cancer miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.miRNA in hepatocellular carcinoma.Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.microRNAs and Neurodegenerative Diseases.MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4.miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.Noncoding RNAs Regulating Cancer Signaling Network.Clinical implications of microRNAs in liver cancer stem cells.MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer."Testing your methyl": DNA methylation profiling of serum DNA of HCC patients.MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7 Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer.HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene.High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth.miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family.Dicer1 Ablation Impairs Responsiveness of Cerebellar Granule Neuron Precursors to Sonic Hedgehog and Disrupts Expression of Distinct Cell Cycle Regulator Genes.miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma.miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.

P2860

Q26771792-817531DF-7F8C-45AC-80AC-0D931D7824C1 Q27011654-03E56DC7-C55C-4D17-986F-F9FACEE6BEA1 Q28076568-44C449B6-CEC5-4BA5-86DF-16C433E25713 Q28077396-A80622CC-E9B0-4432-BB3C-4B10F59DB503 Q33661028-F564C125-238A-4EF5-A50F-FD5624265441 Q34667439-56BDF073-D16F-4A70-B2DF-E693C7A6F9D8 Q34989110-1932ED01-CAE6-4410-BC90-F0B3F6A8FCDA Q35592207-CCA5DA29-A7AE-44F9-B2CC-8F08FF1C9DF1 Q36191096-8095FE0D-472A-4573-A2D2-1F3B72C456F2 Q36255362-02782404-9C0B-4D61-A219-F3E9CAE3E610 Q37349283-6CF4DC4F-AFB4-4170-ABBC-D2423B51FF61 Q37453234-1BB61637-01AD-4A75-9CA4-3F78FADC572A Q37596666-2BCABA28-FC43-436B-8216-FCE36307E755 Q38096240-4CA04F88-A59F-4BEA-89DA-42E8A4140D33 Q38164571-BDA8BE32-3D66-4B5D-B8E0-23B66DC7B5A2 Q38231531-CFC0939A-BCB7-4E61-8B51-224498E01F6E Q38416280-B6EE426B-D6CB-4863-AC0D-38C3BDEA218B Q38668251-8C83BF58-25AF-4178-96D5-8231DF638BA7 Q38730350-B35175FD-4496-422B-904F-6E35DCF4D5BB Q38819406-1CD2BEC4-2721-41A8-9319-C2846DCB9C97 Q38871765-EAAF37BA-F8B1-4023-8180-2A0AEE8551D7 Q38885498-0EE1AF97-925E-4070-AE18-A8DAA1677836 Q39419867-FAB080A6-3427-47E9-82C8-10D64295B211 Q39494968-9FC84C10-E459-435D-97E6-9E45662DE02F Q40707010-69152344-201A-4B1B-8414-F1C8E94E461F Q42368450-D4255C4F-F67E-400E-A5B7-658A68D3EB4D Q42376397-6FB954AA-A43C-46CB-BDFF-69AFEC579F4E Q42951602-216C77CE-570E-4F21-ABAC-7A5AA58C6BE5 Q47169485-D65F1D2E-121D-497A-8263-60336BB94CD1 Q47235299-65C6E2FC-5B9C-456D-AA46-21AD0774D843 Q48527876-9578AFB3-43EF-45AA-B5B6-DEE3CCF87310 Q49209465-83937912-7F43-4E5E-9094-3A2902FC65A6 Q52881471-3BF6B094-FF4E-4178-A8FB-302941EF0068 Q53536512-9AC9A200-EB34-483D-ACCA-9A1A3003779D Q54191926-6363AC9A-17D2-4516-AC51-701E90DE2EAC Q55417805-5B56486F-5451-4B65-8368-181EB195CC7E Q55669243-4C75917E-E6A4-485F-982A-81050FB82165

P2860

miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39255366

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@en

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@nl

type

label

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@en

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@nl

prefLabel

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@en

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@nl

P1433

Q39255366-C9E03204-AA45-44A1-8F8A-2AA6D912CA45

P1476

Q39255366-B2A09A11-76E7-4F2F-A8CC-79E8EF92F82E

P2093

Q39255366-45ABA4B4-BD0D-4A5D-8393-E3360BAA456A

Q39255366-491506B4-6FF7-4E09-BE79-C5B593C7D14C

Q39255366-68095542-BB31-4365-9F8E-A1CD06521A03

Q39255366-AD5FBDEA-23C6-4FC0-93D6-5D5A4E64BA12

Q39255366-D780F7CA-FA2C-4C8D-BCA1-E4035FE0CA9F

P2860

Q39255366-04FB0AFA-94B5-496B-9A3C-D5EDB961B050

Q39255366-0622316C-6D99-4E1E-80C1-A99E5D035D8B

Q39255366-094259EA-3393-4574-A451-26CB7255F738

Q39255366-1A222415-7441-47DC-9DC5-E326B496C0DE

Q39255366-1BD82B75-22EE-4A5C-BC76-79D4532F9F92

Q39255366-1DDE7458-2756-44AC-9B66-AA5E7CD407B6

Q39255366-1F504C67-A511-4C49-85E4-CBF5F5DCE6A2

Q39255366-2AAA88BF-5053-46D3-A951-F3CFF401E0D1

Q39255366-3022257B-DC9B-4363-AACF-72EC1DCF5647

Q39255366-31DC0A62-5C49-4451-B743-FA47976D136F

P304

Q39255366-BF65A8C1-0036-4E9E-9209-4CB38AD7A84B

P31

Q39255366-6B78D6F5-7F16-4A2F-88E9-D72C70C7CA8D

P356

Q39255366-56CE7A35-58EB-43AE-8C44-12C81E050E07

P407

Q39255366-1A89A804-BF82-4C01-845E-6E9959F3BF3B

P433

Q39255366-8B7B14DF-C192-454F-ACA9-ADAB684443AF

P478

Q39255366-399CA36B-58B2-405E-84CF-5B9539B17C0B

P577

Q39255366-B31EAC2F-64A4-4921-8104-9C273A20F39F

P5875

Q39255366-9A1BFF50-4F5E-4810-98D8-E72A4C507C8B

P698

Q39255366-188575C4-E962-4D4C-A03C-C16606471AB5

P356

P1433

P1476

miR-106b downregulates adenoma ...... uman hepatocellular carcinoma.

@en

P2093

Deji Chen

http://www.w3.org/2001/XMLSchema#string

Gang Shen

http://www.w3.org/2001/XMLSchema#string

Hongyun Jia

http://www.w3.org/2001/XMLSchema#string

Qiang Tai

http://www.w3.org/2001/XMLSchema#string

Yanhao Li

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor

Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function

Identification of c-MYC as a target of the APC pathway

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.

cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family

The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro

MicroRNAs: target recognition and regulatory functions

Wnt/beta-catenin signaling: components, mechanisms, and diseases

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

A microRNA polycistron as a potential human oncogene

P304

211-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGS320

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232535038

http://www.w3.org/2001/XMLSchema#string

P698

23087084

http://www.w3.org/2001/XMLSchema#string